Polatuzumab vedotin to treat relapsed or refractory diffuse large B-cell lymphoma, in combination with bendamustine plus rituximab.
Saved in:
| Title: | Polatuzumab vedotin to treat relapsed or refractory diffuse large B-cell lymphoma, in combination with bendamustine plus rituximab. |
|---|---|
| Authors: | Amaya ML; Divisions of Medical Oncology and Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA., Jimeno A; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA. antonio.jimeno@cuanschutz.edu., Kamdar M; Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA. manali.kamdar@cuanschutz.edu. |
| Source: | Drugs of today (Barcelona, Spain : 1998) [Drugs Today (Barc)] 2020 Apr; Vol. 56 (4), pp. 287-294. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Clarivate Analytics Country of Publication: Spain NLM ID: 101160518 Publication Model: Print Cited Medium: Print ISSN: 1699-3993 (Print) Linking ISSN: 16993993 NLM ISO Abbreviation: Drugs Today (Barc) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32309823 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Polatuzumab vedotin to treat relapsed or refractory diffuse large B-cell lymphoma, in combination with bendamustine plus rituximab. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Amaya+ML%22">Amaya ML</searchLink>; Divisions of Medical Oncology and Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Jimeno+A%22">Jimeno A</searchLink>; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA. antonio.jimeno@cuanschutz.edu.<br /><searchLink fieldCode="AU" term="%22Kamdar+M%22">Kamdar M</searchLink>; Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA. manali.kamdar@cuanschutz.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101160518%22">Drugs of today (Barcelona, Spain : 1998)</searchLink> [Drugs Today (Barc)] 2020 Apr; Vol. 56 (4), pp. 287-294. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Clarivate+Analytics%22">Clarivate Analytics </searchLink><i>Country of Publication: </i>Spain <i>NLM ID: </i>101160518 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>1699-3993 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216993993%22">16993993 </searchLink><i>NLM ISO Abbreviation: </i>Drugs Today (Barc) <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32309823 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1358/dot.2020.56.4.3127026 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 287 Titles: – TitleFull: Polatuzumab vedotin to treat relapsed or refractory diffuse large B-cell lymphoma, in combination with bendamustine plus rituximab. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Amaya ML – PersonEntity: Name: NameFull: Jimeno A – PersonEntity: Name: NameFull: Kamdar M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2020 Apr Type: published Y: 2020 Identifiers: – Type: issn-print Value: 1699-3993 Numbering: – Type: volume Value: 56 – Type: issue Value: 4 Titles: – TitleFull: Drugs of today (Barcelona, Spain : 1998) Type: main |
| ResultId | 1 |
